This document reviews 1) the measurement properties of commonly used exercise tests in patients with chronic respiratory diseases and 2) published studies on their utilty and/or evaluation obtained from MEDLINE and Cochrane Library searches between 1990 and March 2015.Exercise tests are reliable and consistently responsive to rehabilitative and pharmacological interventions. Thresholds for clinically important changes in performance are available for several tests. In pulmonary arterial hypertension, the 6-min walk test (6MWT), peak oxygen uptake and ventilation/carbon dioxide output indices appear to be the variables most responsive to vasodilators. While bronchodilators do not always show clinically relevant effects in chronic obstructive pulmonary disease, high-intensity constant work-rate (endurance) tests (CWRET) are considerably more responsive than incremental exercise tests and 6MWTs. High-intensity CWRETs need to be standardised to reduce interindividual variability. Additional physiological information and responsiveness can be obtained from isotime measurements, particularly of inspiratory capacity and dyspnoea. Less evidence is available for the endurance shuttle walk test. Although the incremental shuttle walk test and 6MWT are reliable and less expensive than cardiopulmonary exercise testing, two repetitions are needed at baseline. All exercise tests are safe when recommended precautions are followed, with evidence suggesting that no test is safer than others.

Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement / Puente Maestu, Luis; Palange, Paolo; Casaburi, Richard; Laveneziana, Pierantonio; Maltais, François; Neder, J. Alberto; O'Donnell, Denis E; Onorati, Paolo; Porszasz, Janos; Rabinovich, Roberto; Rossiter, Harry B; Singh, Sally; Troosters, Thierry; Ward, Susan. - In: EUROPEAN RESPIRATORY JOURNAL. - ISSN 0903-1936. - 47:2(2016), pp. 429-60-460. [10.1183/13993003.00745-2015]

Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement

PALANGE, Paolo;ONORATI, Paolo;
2016

Abstract

This document reviews 1) the measurement properties of commonly used exercise tests in patients with chronic respiratory diseases and 2) published studies on their utilty and/or evaluation obtained from MEDLINE and Cochrane Library searches between 1990 and March 2015.Exercise tests are reliable and consistently responsive to rehabilitative and pharmacological interventions. Thresholds for clinically important changes in performance are available for several tests. In pulmonary arterial hypertension, the 6-min walk test (6MWT), peak oxygen uptake and ventilation/carbon dioxide output indices appear to be the variables most responsive to vasodilators. While bronchodilators do not always show clinically relevant effects in chronic obstructive pulmonary disease, high-intensity constant work-rate (endurance) tests (CWRET) are considerably more responsive than incremental exercise tests and 6MWTs. High-intensity CWRETs need to be standardised to reduce interindividual variability. Additional physiological information and responsiveness can be obtained from isotime measurements, particularly of inspiratory capacity and dyspnoea. Less evidence is available for the endurance shuttle walk test. Although the incremental shuttle walk test and 6MWT are reliable and less expensive than cardiopulmonary exercise testing, two repetitions are needed at baseline. All exercise tests are safe when recommended precautions are followed, with evidence suggesting that no test is safer than others.
2016
Advisory Committees; Breath Tests; Carbon Dioxide; Dyspnea; Europe; Exercise Test; Humans; Hypertension, Pulmonary; Inspiratory Capacity; Oxygen Consumption; Pulmonary Disease, Chronic Obstructive; Pulmonary Medicine; Pulmonary Ventilation; Reproducibility of Results; Respiratory Tract Diseases; Societies, Medical; Walking; Exercise Tolerance; Outcome Assessment (Health Care)
01 Pubblicazione su rivista::01a Articolo in rivista
Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement / Puente Maestu, Luis; Palange, Paolo; Casaburi, Richard; Laveneziana, Pierantonio; Maltais, François; Neder, J. Alberto; O'Donnell, Denis E; Onorati, Paolo; Porszasz, Janos; Rabinovich, Roberto; Rossiter, Harry B; Singh, Sally; Troosters, Thierry; Ward, Susan. - In: EUROPEAN RESPIRATORY JOURNAL. - ISSN 0903-1936. - 47:2(2016), pp. 429-60-460. [10.1183/13993003.00745-2015]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/965287
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 83
  • Scopus 314
  • ???jsp.display-item.citation.isi??? 293
social impact